Hiemstra P S, Brands-Tajouiti J, van Furth R
Department of Infectious Diseases, University Hospital Leiden, The Netherlands.
J Lab Clin Med. 1994 Feb;123(2):241-6.
In the present study the level of antimicrobial antibodies and the phagocytosis-promoting activity in immunoglobulin preparations produced for intravenous use were assessed. The level of antibodies directed against various microorganisms in six immunoglobulin preparations was determined by using an enzyme-linked immunosorbent assay (ELISA) and was shown to be either equal to or higher than that of pooled normal human serum. All preparations were able to promote phagocytosis of Staphylococcus aureus, Escherichia coli K12, and Streptococcus pyogenes by human granulocytes. Substantial differences among the various preparations in antibody activity were noted. In particular, Intraglobulin, chemically modified by beta-propiolactone treatment, exhibited little activity in both the ELISA and the phagocytosis assay. In contrast, IVIG SRC, Gamimmune, Sandoglobulin (treated at low pH in presence or absence of trace amounts of pepsin), and Gammagard (treated by ion-exchange chromatography) showed good activity in both assays. Comparison of the results of the ELISA and phagocytosis assay for the various preparations indicated a good correlation except for S. aureus with a moderate (strain 42D) or high (strain Cowan I) protein A content. These data indicate that the antibody activity of immunoglobulin preparations against various microorganisms determined by ELISA can be used to predict their opsonic activity.
在本研究中,对静脉注射用免疫球蛋白制剂中的抗菌抗体水平和促吞噬活性进行了评估。采用酶联免疫吸附测定法(ELISA)测定了六种免疫球蛋白制剂中针对各种微生物的抗体水平,结果显示其抗体水平等于或高于混合正常人血清。所有制剂均能促进人粒细胞对金黄色葡萄球菌、大肠杆菌K12和化脓性链球菌的吞噬作用。各制剂之间在抗体活性方面存在显著差异。特别是,经β-丙内酯处理化学修饰的Intraglobulin在ELISA和吞噬试验中均表现出较低活性。相比之下,IVIG SRC、Gamimmune、Sandoglobulin(在有或无微量胃蛋白酶存在的情况下在低pH下处理)和Gammagard(通过离子交换色谱法处理)在两种试验中均表现出良好活性。对各制剂的ELISA和吞噬试验结果进行比较表明,除了含有中等(菌株42D)或高(Cowan I菌株)蛋白A含量的金黄色葡萄球菌外,两者具有良好的相关性。这些数据表明,通过ELISA测定的免疫球蛋白制剂针对各种微生物的抗体活性可用于预测其调理活性。